+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Japan Next Generation Sequencing Market Size, Share & Trends Analysis Report by Technology (Targeted Sequencing & Resequencing), Product (Platforms, Consumables) by Application, Workflow, End-use, and Segment Forecasts, 2024-2030

  • PDF Icon

    Report

  • 200 Pages
  • November 2023
  • Region: Japan
  • Grand View Research
  • ID: 5914534
Description Jump to:
The Japan next generation sequencing market size is expected to reach USD 1,305.67 million by 2030, registering a CAGR of 23.60% from 2024 to 2030, according to the report. Factors such as the development of companion diagnostics and personalized medicine and rising clinical opportunities for NGS technology are projected to drive the market growth. In addition, rising competition in the market owing to high consumer demand and the rising emphasis of market players to develop next-generation sequencing products and services is another vital factor propelling industry demand forward.

With lowering costs, the adoption of next-generation sequencing in the clinical setting is boosting. Moreover, an increase in the demand for clinic-based NGS solutions is anticipated to propel the next generation sequencing industry over the forecast period. The utilization of genome sequencing and MPSS /NGS has become necessary for the diagnosis & analysis of rare diseases, and recognizing therapeutic targets, and for prenatal testing. NGS is anticipated to witness rising adoption in hereditary diseases and infectious disorder treatment. Furthermore, companies are providing products and services based on NGS for rare and hereditary diseases. For instance, in January 2023, Twist Bioscience Corporation, An NGS service provider in Japan, introduced three NGS target enrichment panels to support hereditary cancer research and rare diseases and support diagnostics. Such product launches by key players operating in the country are anticipated to drive market growth over the forecast period.

The developments of companion diagnostics and personalized medicines are anticipated to drive the adoption of next-generation sequencing products and services. Several oncologists expected that NGS combined with companion diagnostics could play a major role in personalized diagnostics and therapeutics, significantly increasing the demand for NGS applications. Furthermore, regulatory authorities are also supporting the use of NGS for companion diagnostics. For instance, in September 2021, the Ministry of Health, Labour, and Welfare (MHLW), Japan, authorized the Oncomine Dx Target Test, a companion diagnostic (CDx) from Thermo Fisher Scientific Inc. The Oncomine test was approved as an NGS-based CDx for lung cancer. Such developments, coupled with regulatory support, are anticipated to boost the market growth over the forecast period.

Japan Next Generation Sequencing Market Report Highlights

  • Based on product, the consumables segment dominated the industry in 2023 with a revenue share of 74.0%, and this dominance can be attributed to the decrease in sequencing costs and increasing launches of consumables by major players
  • Based on application, the oncology segment was the largest revenue contributor for the industry in 2023. In contrast, the consumer genomics segment is expected to witness the fastest growth owing to the rapid development in personal health awareness, paternity testing, and genealogy
  • Based on workflow, the sequencing segment dominated the market in 2023. The higher revenue of the segment is attributed to the availability of various sequencing platforms
  • Based on technology, the targeted sequencing & resequencing segment dominated the industry in 2023 and is projected to register the highest growth rate during the forecast period
  • Based on end-use, the academic research segment dominated the industry in 2023 due to numerous academic institutes providing bioinformatics courses

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Technology
1.1.2. Product
1.1.3. Application
1.1.4. Workflow
1.1.5. End-use
1.1.6. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. Internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Snapshot
2.3. Competitive Insights
Chapter 3. Japan Next Generation Sequencing Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Exponentially decreasing costs for genetic sequencing
3.2.1.2. Development of companion diagnostics and personalized medicine
3.2.1.3. Rise in competition among prominent market entities
3.2.1.4. Rising clinical opportunity for NGS technology
3.2.1.5. Technological advancements in cloud computing and data integration
3.2.1.6. Growing healthcare expenditure supporting development of effective diagnostic & therapeutic procedures for cancer.
3.2.1.7. Increasing prevalence of cancer
3.2.2. Market restraint analysis
3.2.2.1. Lack of computational efficiency for data management
3.2.2.2. Non-value-based NGS reimbursement policy and regulation status
3.2.2.3. Challenges associated with NGS implementation.
3.3. Japan Next Generation Sequencing Market Analysis Tools
3.3.1. SWOT analysis; by factor (political & legal, economic, and technological)
3.3.2. Porter’s Five Forces Analysis
3.3.3. COVID-19 Impact Analysis
Chapter 4. Japan Next Generation Sequencing Market: Technology Business Analysis
4.1. Next Generation Sequencing Market: Technology Movement Analysis
4.2. Targeted Sequencing & Resequencing
4.2.1. Targeted Sequencing & Resequencing Market Estimates And Forecast, 2018 - 2030 (USD Million)
4.2.1.1. DNA-based targeted sequencing & resequencing
4.2.1.1.1. DNA-based targeted sequencing & resequencing market estimates and forecast, 2018 - 2030 (USD Million)
4.2.1.2. RNA-based targeted sequencing & resequencing
4.2.1.2.1. RNA-based targeted sequencing & resequencing market estimates and forecast, 2018 - 2030 (USD Million)
4.3. Whole Genome Sequencing
4.3.1. Whole Genome Sequencing Market Estimates And Forecast, 2018 - 2030 (USD Million)
4.4. Whole Exome Sequencing
4.4.1. Whole Exome Sequencing Market Estimates And Forecast, 2018 - 2030 (USD Million)
Chapter 5. Japan Next Generation Sequencing Market: Product Business Analysis
5.1. Next Generation Sequencing Market: Product Movement Analysis
5.2. Platforms
5.2.1. Platforms Market Estimates And Forecast, 2018 - 2030 (USD Million)
5.2.1.1. Sequencing
5.2.1.1.1. Sequencing platforms market estimates and forecast, 2018 - 2030 (USD Million)
5.2.1.2. Data Analysis
5.2.1.2.1. Data analysis platforms market estimates and forecast, 2018 - 2030 (USD Million
5.3. Consumables
5.3.1. Consumables market estimates and forecast, 2018 - 2030 (USD million)
5.3.2. Sample Preparation
5.3.2.1. Sample preparation market estimates and forecast, 2018 - 2030 (USD Million)
5.3.3. Target Enrichment
5.3.3.1. Target enrichment market estimates and forecast, 2018 - 2030 (USD Million)
5.3.4. Others
5.3.4.1. Others market estimates and forecast, 2018 - 2030 (USD Million)
Chapter 6. Japan Next Generation Sequencing Market: Application Business Analysis
6.1. Next Generation Sequencing Market: Application Movement Analysis
6.2. Oncology
6.2.1. Oncology Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.2.2. Diagnostics & Screening
6.2.2.1. Diagnostics & screening market estimates and forecast, 2018 - 2030 (USD Million)
6.2.2.2. Oncology screening
6.2.2.2.1. Oncology screening market estimates and forecast, 2018 - 2030 (USD Million)
6.2.2.2.2. Sporadic cancer screening market estimates and forecast, 2018 - 2030 (USD Million)
6.2.2.2.3. Inherited cancer screening market estimates and forecast, 2018 - 2030 (USD Million)
6.2.2.3. Companion diagnostics
6.2.2.3.1. Companion diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
6.2.2.4. Other diagnostics
6.2.2.4.1. Other diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
6.2.3. Research Studies
6.2.3.1. Research studies market estimates and forecast, 2018 - 2030 (USD Million)
6.3. Clinical investigation
6.3.1. Clinical investigation market estimates and forecast, 2018 - 2030 (USD Million)
6.3.2. Infectious Diseases
6.3.2.1. Infectious diseases market estimates and forecast, 2018 - 2030 (USD Million)
6.3.3. Idiopathic Diseases
6.3.3.1. Idiopathic diseases market estimates and forecast, 2018 - 2030 (USD Million)
6.3.4. Inherited Diseases
6.3.4.1. Inherited diseases market estimates and forecast, 2018 - 2030 (USD Million)
6.3.5. Non-Communicable/Other Diseases
6.3.5.1. Non-communicable/other diseases market estimates and forecast, 2018 - 2030 (USD Million)
6.4. Reproductive Health
6.4.1. Reproductive Health Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.4.2. NIPT
6.4.2.1. NIPT market estimates and forecast, 2018 - 2030 (USD Million)
6.4.2.2. Aneuploidy
6.4.2.2.1. Aneuploidy market estimates and forecast, 2018 - 2030 (USD Million)
6.4.2.3. Microdeletions
6.4.2.3.1. Microdeletions market estimates and forecast, 2018 - 2030 (USD Million)
6.4.3. PGT
6.4.3.1. PGT market estimates and forecast, 2018 - 2030 (USD Million)
6.4.4. Newborn Genetic Screening
6.4.4.1. Newborn genetic screening market estimates and forecast, 2018 - 2030 (USD Million)
6.4.5. Single Gene Analysis
6.4.5.1. Single gene analysis market estimates and forecast, 2018 - 2030 (USD Million)
6.5. HLA Typing/Immune System Monitoring
6.5.1. HLA Typing/Immune System Monitoring Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.6. Metagenomics, Epidemiology & Drug Development
6.6.1. Metagenomics, Epidemiology & Drug Development Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.7. Agrigenomics & Forensics
6.7.1. Agrigenomics & Forensics Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.8. Consumer Genomics
6.8.1. Consumer Genomics Market Estimates And Forecast, 2018 - 2030 (USD Million)
Chapter 7. Japan Next Generation Sequencing Market: Workflow Business Analysis
7.1. Next Generation Sequencing Market: Workflow Movement Analysis
7.2. Presequencing
7.2.1. Pre-Sequencing Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.2.1.1. NGS library preparation kits
7.2.1.1.1. NGS library preparation kits market estimates and forecast, 2018 - 2030 (USD Million)
7.2.1.2. Semiautomated library preparation
7.2.1.2.1. Semiautomated library preparation market estimates and forecast, 2018 - 2030 (USD Million)
7.2.1.3. Automated library preparation
7.2.1.3.1. Automated library preparation market estimates and forecast, 2018 - 2030 (USD Million)
7.3. Sequencing
7.3.1. Sequencing Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.4. Data Analysis
7.4.1. Data Analysis Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.4.2. Primary Data Ngs Analysis
7.4.2.1. Primary data analysis market estimates and forecast, 2018 - 2030 (USD Million)
7.4.3. Secondary Data Analysis
7.4.3.1. Secondary data analysis market estimates and forecast, 2018 - 2030 (USD Million)
7.4.4. Tertiary Data Analysis
7.4.4.1. Tertiary data analysis market estimates and forecast, 2018 - 2030 (USD Million)
Chapter 8. Japan Next Generation Sequencing Market: End-use Business Analysis
8.1. Next Generation Sequencing Market: End-use Movement Analysis
8.2. Academic Research
8.2.1. Academic Research Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.3. Clinical Research
8.3.1. Clinical Research Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.4. Hospitals & Clinics
8.4.1. Hospitals & Clinics Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.5. Pharmaceutical & Biotech Entities
8.5.1. Pharmaceutical & Biotech Entities Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.6. Other Users
8.6.1. Other Users Market Estimates And Forecast, 2018 - 2030 (USD Million)
Chapter 9. Competitive Landscape
9.1. Recent Developments & Impact Analysis, By Key Market Participants
9.2. Company/Competition Categorization
9.3. Key company market share analysis, 2023
9.4. Participants Overview
9.4.1. Illumina, Inc
9.4.1.1. Company overview
9.4.1.2. Financial performance
9.4.1.3. Product benchmarking
9.4.1.4. Strategic initiatives
9.4.2. QIAGEN
9.4.2.1. Company overview
9.4.2.2. Financial performance
9.4.2.3. Product benchmarking
9.4.2.4. Strategic initiatives
9.4.3. Thermo Fisher Scientific, Inc
9.4.3.1. Company overview
9.4.3.2. Financial performance
9.4.3.3. Product benchmarking
9.4.3.4. Strategic initiatives
9.4.4. BGI
9.4.4.1. Company overview
9.4.4.2. Financial performance
9.4.4.3. Product benchmarking
9.4.4.4. Strategic initiatives
9.4.5. Pacific Biosciences
9.4.5.1. Company overview
9.4.5.2. Financial performance
9.4.5.3. Product benchmarking
9.4.5.4. Strategic initiatives
9.4.6. Bio Rad Laboratories
9.4.6.1. Company overview
9.4.6.2. Financial performance
9.4.6.3. Product benchmarking
9.4.6.4. Strategic initiatives
9.4.7. Oxford Nanopore Technologies, Inc
9.4.7.1. Company overview
9.4.7.2. Financial performance
9.4.7.3. Product benchmarking
9.4.7.4. Strategic initiatives
9.4.8. Myriad Genetics. Inc.
9.4.8.1. Company overview
9.4.8.2. Financial performance
9.4.8.3. Product benchmarking
9.4.8.4. Strategic initiatives
9.4.9. Agilent Technologies, Inc.
9.4.9.1. Company overview
9.4.9.2. Financial performance
9.4.9.3. Product benchmarking
9.4.9.4. Strategic initiatives
9.4.10. Eurofins Scientific
9.4.10.1. Company overview
9.4.10.2. Financial performance
9.4.10.3. Product benchmarking
9.4.10.4. Strategic initiatives
List of Tables
Table 1 List of Abbreviation
Table 2 Japan next generation sequencing market, by technology, 2018 - 2030 (USD Million)
Table 3 Japan next generation sequencing market, by product, 2018 - 2030 (USD Million)
Table 4 Japan next generation sequencing market, by application, 2018 - 2030 (USD Million)
Table 5 Japan next generation sequencing market, by workflow, 2018 - 2030 (USD Million)
Table 6 Japan next generation sequencing market, by end-use, 2018 - 2030 (USD Million)
List of Figures
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Market formulation & validation
Fig. 6 Japan next generation sequencing market: market outlook
Fig. 7 Japan next generation sequencing competitive insights.
Fig. 8 Parent market outlook
Fig. 9 Related/ancillary market outlook.
Fig. 10 Penetration and growth prospect mapping
Fig. 11 Industry value chain analysis
Fig. 12 Japan next generation sequencing market driver impact
Fig. 13 Japan next generation sequencing market restraint impact
Fig. 14 Japan next generation sequencing market strategic initiatives analysis
Fig. 15 Japan next generation sequencing market: Technology movement analysis
Fig. 16 Japan next generation sequencing market: Technology outlook and key takeaways
Fig. 17 Targeted sequencing & resequencing market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 18 DNA-based targeted sequencing & resequencing market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 19 RNA -based targeted sequencing & resequencing market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 20 Whole genome sequencing market estimates and forecast, 2018-2030 (USD Million)
Fig. 21 Whole exome sequencing market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 22 Japan Next-generation sequencing market: Product outlook key takeaways
Fig. 23 Japan Next-generation sequencing market: Product movement analysis
Fig. 24 Platforms market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 25 Sequencing platforms market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 26 Data analysis platforms market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 27 Consumables market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 28 Sample preparation market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 29 Target enrichment market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 30 Others market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 31 Japan next generation sequencing Market: Application Movement Analysis
Fig. 32 Japan next generation sequencing market: Application outlook and key takeaways
Fig. 33 Oncology market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 34 Diagnostics & screening market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 35 Oncology screening market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 36 Sporadic cancer screening market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 37 Inherited cancer screening market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 38 Companion diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 39 Other diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 40 Research studies market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 41 Clinical investigation market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 42 Infectious diseases market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 43 Idiopathic diseases market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 44 Inherited diseases market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 45 Non-communicable/other diseases market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 46 Reproductive health market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 47 NIPT market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 48 Aneuploidy market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 49 Microdeletions market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 50 PGT market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 51 Newborn genetic screening market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 52 Single gene analysis market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 53 HLA typing/immune system monitoring market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 54 Metagenomics, epidemiology & drug development market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 55 Agrigenomics & forensics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 56 Consumer genomics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 57 Japan next generation sequencing market: workflow movement analysis
Fig. 58 Japan next generation sequencing market: workflow outlook and key takeaways
Fig. 59 Pre-sequencing market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 60 NGS library preparation kits market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 61 Semiautomated library preparation market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 62 Automated library preparation market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 63 Sequencing market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 64 Data analysis market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 65 Primary data analysis market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 66 Secondary data analysis market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 67 Tertiary data analysis market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 68 Japan Next generation sequencing market End-use outlook key takeaways
Fig. 69 Japan Next-generation sequencing market: End-use movement analysis
Fig. 70 Academic research market estimates and forecast, 2018 - 2030 (USD Million))
Fig. 71 Clinical research market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 72 Hospitals & clinics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 73 Pharmaceutical & biotech entities market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 74 Other users market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 75 Market share of key market players- Japan next generation sequencing market

Companies Profiled

  • Illumina, Inc
  • QIAGEN
  • Thermo Fisher Scientific, Inc
  • BGI
  • Pacific Biosciences
  • Bio Rad Laboratories
  • Oxford Nanopore Technologies, Inc
  • Myriad Genetics. Inc.
  • Agilent Technologies, Inc.
  • Eurofins Scientific

Methodology

Loading
LOADING...

Related Topics

Related Reports

Next Generation Sequencing Market Size, Share & Trends Analysis Report by Technology (WGS, Targeted Sequencing & Resequencing), Product (Platform, Consumables), Application, Workflow, End-use, Region, and Segment Forecasts, 2024-2030 - Product Image

Next Generation Sequencing Market Size, Share & Trends Analysis Report by Technology (WGS, Targeted Sequencing & Resequencing), Product (Platform, Consumables), Application, Workflow, End-use, Region, and Segment Forecasts, 2024-2030

  • Report
  • 300 Pages
  • Global
From
Next-generation Sequencing Library Preparation Market Size, Share & Trends Analysis Report By Sequencing Type (Targeted Genome Sequencing, Whole Genome Sequencing), By Product, By Application, By End-use, By Region, And Segment Forecasts, 2024 - 2030 - Product Image

Next-generation Sequencing Library Preparation Market Size, Share & Trends Analysis Report By Sequencing Type (Targeted Genome Sequencing, Whole Genome Sequencing), By Product, By Application, By End-use, By Region, And Segment Forecasts, 2024 - 2030

  • Report
  • 120 Pages
  • Global
From
Next-Generation Sequencing Market Report by Sequencing Type, Product Type, Technology, Application, End-User, and Region 2024-2032 - Product Image

Next-Generation Sequencing Market Report by Sequencing Type, Product Type, Technology, Application, End-User, and Region 2024-2032

  • Report
  • 142 Pages
  • Global
From
Next Generation Sequencing CLIA Laboratory Services Market by Technology, Certificate Types, Application, End-users - Global Forecast 2025-2030 - Product Image

Next Generation Sequencing CLIA Laboratory Services Market by Technology, Certificate Types, Application, End-users - Global Forecast 2025-2030

  • Report
  • 183 Pages
  • Global
From
Clinical Oncology Next-Generation Sequencing Market by Technology, by Workflow, by Application, by End-user, and by Region - Product Image

Clinical Oncology Next-Generation Sequencing Market by Technology, by Workflow, by Application, by End-user, and by Region

  • Report
  • 200 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.